← Eichor
Condition: Hemophilia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hemophilia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Liver Biopsy In Haemophilia Gene Therapy
NA · 1 location(s) · University College, London · NCT04817462Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys
Phase 4 · 1 location(s) · Runhui WU · NCT06864975Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VII
Phase N/A · 10 location(s) · Wayne State University · NCT05022459Lentiviral FIX Gene Therapy
Phase 1 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03961243An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hem
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05849740The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05630651The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Phase N/A · 39 location(s) · PedNet Haemophilia Research Foundation · NCT02979119An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With
Phase 3 · 14 location(s) · Biocad · NCT06700096A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Phase 1 · 7 location(s) · Pfizer · NCT06703606Synovial Proliferation on Routine Ultrasound: Active or Inactive?
Phase N/A · 1 location(s) · Van Creveldkliniek · NCT06809972Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery
Phase 4 · 1 location(s) · Konkuk University Medical Center · NCT06144125A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Phase 1/Phase 2 · 2 location(s) · Hoffmann-La Roche · NCT07226206Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · 51 location(s) · Duke University · NCT04278404A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants
Phase N/A · 1 location(s) · Bayer · NCT06222697Hemophilia A Research Program
Phase N/A · 1 location(s) · University of Washington · NCT07414511Pharmacokinetic-guided Dosing of Emicizumab
Phase 4 · 8 location(s) · Kathelijn Fischer · NCT06320626ATHNdataset Registry
Phase N/A · 1 location(s) · American Thrombosis and Hemostasis Network · NCT06820515Gene Therapy for Chinese Hemophilia A
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04728841Multidimensional Assessment of Chronic Pain in Severe Haemophilia A
Phase N/A · 1 location(s) · Investigación en Hemofilia y Fisioterapia · NCT07096349A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Phase 3 · 12 location(s) · Hoffmann-La Roche · NCT07416604Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
Phase 2/Phase 3 · 10 location(s) · Shanghai Xinzhi BioMed Co., Ltd. · NCT06111638A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI
Phase N/A · 1 location(s) · Haemophilia Centre Rhine Main · NCT02207894Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Phase 4 · 13 location(s) · Sanofi · NCT06941870High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Phase N/A · 1 location(s) · Yigeng Cao,MD,PhD · NCT07205523ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05888870An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic
Phase 1/Phase 2 · 9 location(s) · Shanghai RAAS Blood Products Co., Ltd. · NCT07644832A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With
Phase 1/Phase 2 · 14 location(s) · Hoffmann-La Roche · NCT05987449Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.
Phase 3 · 19 location(s) · Hangzhou Gensciences Biopharmaceutical Co., Ltd. · NCT07684898ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · 71 location(s) · American Thrombosis and Hemostasis Network · NCT04398628Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
Phase 3 · 28 location(s) · Hangzhou Gensciences Biopharmaceutical Co., Ltd. · NCT06142552
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.